Poster Presentation: Quantification of Cytokines on the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform using Alpha Technology
20 Sept 2011
Watch this poster presentation, filmed at ELRIG Drug Discovery 2011 to see Caroline Cardonnel Ph.D. present: Quantification of cytokines on the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform using Alpha Technology.
About the company

Molecular Devices®
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
General Inquiry - USA & Canada: +1 800-635-5577 General Inquiry - Europe: 00800 665 32860 Sales +1 877-589-2214 Support +1 800 635 5577












